MetaADEDB 2.0 @ LMMD
Pantoprazole magnesium
(RDRUTBCDIVCMMX-UHFFFAOYSA-N)
Structure
SMILES
COc1c(OC)ccnc1CS(=O)c1[n-]c2c(n1)cc(cc2)OC(F)F.COc1c(OC)ccnc1CS(=O)c1[n-]c2c(n1)cc(cc2)OC(F)F.[Mg+2]
Molecular Formula:
C32H28F4MgN6O8S2
Molecular Weight:
789.029
Log P:
6.7582
Hydrogen Bond Acceptor:
12
Hydrogen Bond Donor:
0
TPSA:
205.28
CAS Number(s):
199387-73-0; 1022083-88-0
Synonym(s)
1.
Pantoprazole magnesium
External Link(s)
PubChem Compound71587624
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Atrial FibrillationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
2Drug ineffectiveFAERS: 1
Canada Vigilance: 21
Canada Vigilance
US FAERS
3DyspepsiaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
4PancytopeniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
5Abdominal PainCanada Vigilance: 2Canada Vigilance
6Abdominal discomfortCanada Vigilance: 1Canada Vigilance
7Anaphylactic shockCanada Vigilance: 1Canada Vigilance
8AnxietyCanada Vigilance: 1Canada Vigilance
9ArthralgiaCanada Vigilance: 1Canada Vigilance
10Burning sensationCanada Vigilance: 1Canada Vigilance
11ConstipationCanada Vigilance: 1Canada Vigilance
12DizzinessCanada Vigilance: 1Canada Vigilance
13Eye irritationCanada Vigilance: 1Canada Vigilance
14HeadacheCanada Vigilance: 3Canada Vigilance
15NauseaCanada Vigilance: 4Canada Vigilance
16Product formulation issueCanada Vigilance: 1Canada Vigilance
17Product substitution issueCanada Vigilance: 7Canada Vigilance
18Therapeutic product effect decreasedCanada Vigilance: 1Canada Vigilance
19Therapy non-responderCanada Vigilance: 3Canada Vigilance
20VomitingCanada Vigilance: 3Canada Vigilance
21treatment failureCanada Vigilance: 3Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.